Virscio extends expertise to molecular biology with new division launch

We are thrilled to announce the launch of Virscio's new molecular biology division, a significant milestone in our ongoing commitment to advancing translational research and development. This new division will expand our capabilities, allowing us to offer a full range of services that enable better-informed mission-critical decisions, de-risk development, and accelerate the delivery of cutting-edge therapeutics to patients.

 Comprehensive Molecular Biology Services

Our molecular biology platfrom provides an array of advanced services, including:

• High-throughput sample tissue processing: established methods for isolation and quantification of DNA, RNA, and protein from diverse tissue types.
• Comprehensive method development, quantification, and validation capabilities:
  • Absolute quantification and reference gene-based AAV biodistribution assays
  • Development and validation of vector and therapeutic cell biodistribution assays
  • Gene expression profiling and genome edit detection assays
  • Method development, validation, and sample analysis for Western blot assays
  • Validation of commercially available ELISA assays and sample analysis
  • AAV-antisera quantification assays

Enhancing Research Integration

Our team of experienced molecular biologists and research scientists will collaborate closely with our in-life translational teams to ensure seamless integration of molecular biology data with in vivo findings. This collaborative approach will enhance the interpretation of study outcomes, deepen understanding of mechanisms of action, and support critical decisions in drug development programs. 

Committed to Advancing Therapeutic Development

"The launch of our molecular biology capabilities marks a significant milestone in Virscio's ongoing commitment to advancing translational research," said Dr. Matthew Lawrence, CEO of Virscio. "By providing comprehensive molecular biology services, we aim to further position Virscio as a premier provider of translational R&D services."

We invite you to explore our new molecular biology services and learn how our expanded capabilities can support your research and development needs. Click here to read the press release, or contact us today for more information!